Shandong Aishi Biotechnology
Tesamorelin
Finnrick tested 5 samples of Tesamorelin from Shandong Aishi Biotechnology between 11 Dec 2025 and 27 May 2026. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).
Finnrick Rating™
Tentative Rating
Shandong Aishi Biotechnology
Tesamorelin
Tested 5 Samples
Last test 27 May 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tesamorelin tests from top-rated vendors:
All Tesamorelin tests from Shandong Aishi Biotechnology
Samples are tested in commercial labs
Tests Count
5
Scores
AVGMINMAX
Last
27 May 2026
First
11 Dec 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 27 May 2026 | View | 10mg | 4.65mg | -53.5% | 99.10% | 12/2/2025 | No label / Silver crimp / White cap | Lab E | Public | |
| 20 Feb 2026 | View | 10mg | 5.23mg | -47.7% | 99.70% | 25-SS30 | White Label / Silver Crimp / White Cap | Lab E | Public | |
| 4 Feb 2026 | View | 10mg | 11.1mg | +11.0% | 99.56% | AS251206 | No Label / Silver Crimp / Black Cap | Lab E | Public | |
| 2 Feb 2026 | View | 10mg | 10.7mg | +7.0% | 99.90% | Dec 2, 2025 | No Label / Silver Crimp / Black Cap | Lab E | Public | |
| 11 Dec 2025 | View | 10mg | 13.6mg | +36.0% | 99.95% | Oct. 19 2025 | No Label / Silver Crimp / Black Cap | Lab E | Public | |